KINVENT BIOMECANIQUE announced that it has raised ?16 million in an equity round of funding led by new investor, NOV Santé Actions Non Cotées, a fund managed by Eurazeo SE on January 18, 2024. The transaction included participation from the founder and other returning minority shareholders. NOV Santé Actions Non Cotées, a fund managed by Eurazeo SE will acquire minority stake in the company.